Patient Enrollment for Phase II Arthritis Drug Trial in US & Europe
Challenge: Meet the one year enrollment timeline for this 216 patient study. When WCG ThreeWire was engaged...
Most Recent Flipbooks
WCG ThreeWire— Endometriosis
Case Study: Retrospective Endpoint Adjudication Committee
WCG ThreeWire– Oncology Study
WCG ThreeWire– UC Crohn's Study
WCG ThreeWire– Vaccine Study for Top 10 Pharma
WCG ThreeWire– Psoriatic Arthritis
How Celgene Transformed Its Safety-Reporting Process, Saving $5.7 million In One Year
Accurate Pain Reporting
WCG Analgesic Solutions found that patients could better report their pain intensity and discriminate between active drug and placebo using accurate pain reporting training.
By the Numbers: Six Challenges to Enrollment, One Customized Solution
How a Top Pharma Company Successfully Enrolled for a MDD Study
ThreeWire was able to quickly review charts at the 48 sites, leading to 121 consents and 69 enrolled subjects. These efforts contributed 34.5% of all enrollments.
How a Sponsor Secured 200 High-Performing PI's in a New TA in Just 5 Days
Global Osteoarthritis Program facing FDA Safety Concerns
Finding an Agile PV Partner for Early-Stage Clinical Development
Rescuing Two Global Immuno-Oncology Trials with Contracts & Budgets
Partnering for the Future: Rescuing Contracts & Budgets for 10 Global Phase II & III Studies
OhioHealth Case Study
Dissatisfied with its electronic IRB research management solution, OhioHealth Research & Innovation Institute searched for a solution to improve compliance, efficiency, customer service, and cost.
Recruitment Case Study for Osteoarthritis Pain Program
WCG ThreeWire Recruitment Success: 70% of Total Randomization
Study Marketing for Medical Device Sleep Study - US
Enrollment Services Phase III Oncology Drug Study - US & Europe